Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula De Vos

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Isis; an International Review Devoted to the History of Science and Its Cultural Influences|May 3, 2014
The "Prince of Medicine": Yūhannā ibn Māsawayh and the foundations of the western pharmaceutical traditionPaula De Vos
Endeavour|September 11, 2003
An herbal El Dorado: the quest for botanical wealth in the Spanish EmpirePaula De Vos
Journal of Ethnopharmacology|June 22, 2010
European materia medica in historical texts: longevity of a tradition and implications for future usePaula De Vos
History of Science|June 20, 2017
Methodological challenges involved in compiling the Nahua pharmacopeiaPaula De Vos
Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2007
Total body ABCG1 expression protects against early atherosclerotic lesion development in miceRuud Out, Menno Hoekstra, Illiana Meurs, et al.
Cardiovascular Research|February 6, 2008
Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Paula de Vos, M Gabriele Bixel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2006
Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Gijs H M van Puijvelde, Paula de Vos, et al.
The Journal of Biological Chemistry|February 19, 2004
Scavenger receptor BI plays a role in facilitating chylomicron metabolismRuud Out, J Kar Kruijt, Patrick C N Rensen, et al.
Thrombosis and Haemostasis|August 5, 2009
Effect of natural killer T cell activation on the initiation of atherosclerosisGijs H M van Puijvelde, Eva J A van Wanrooij, Arnaud D Hauer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2005
HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Hester Happé, Arnaud D Hauer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Isis; an International Review Devoted to the History of Science and Its Cultural Influences|May 3, 2014
The "Prince of Medicine": Yūhannā ibn Māsawayh and the foundations of the western pharmaceutical traditionPaula De Vos
Endeavour|September 11, 2003
An herbal El Dorado: the quest for botanical wealth in the Spanish EmpirePaula De Vos
Journal of Ethnopharmacology|June 22, 2010
European materia medica in historical texts: longevity of a tradition and implications for future usePaula De Vos
History of Science|June 20, 2017
Methodological challenges involved in compiling the Nahua pharmacopeiaPaula De Vos
Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2007
Total body ABCG1 expression protects against early atherosclerotic lesion development in miceRuud Out, Menno Hoekstra, Illiana Meurs, et al.
Cardiovascular Research|February 6, 2008
Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Paula de Vos, M Gabriele Bixel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2006
Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Gijs H M van Puijvelde, Paula de Vos, et al.
The Journal of Biological Chemistry|February 19, 2004
Scavenger receptor BI plays a role in facilitating chylomicron metabolismRuud Out, J Kar Kruijt, Patrick C N Rensen, et al.
Thrombosis and Haemostasis|August 5, 2009
Effect of natural killer T cell activation on the initiation of atherosclerosisGijs H M van Puijvelde, Eva J A van Wanrooij, Arnaud D Hauer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2005
HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Hester Happé, Arnaud D Hauer, et al.
Pageof 2